Puerto, Jershon L.

HRN: 22-60-13  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/12/2023
04/19/2023
IV
2.25g
Q8h
Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: